Molecular modeling in cardiovascular pharmacology: current state of the art and perspectives

Jennifer Lagoutte-Renosi was awarded a PhD in pharmacology in 2017. She is currently a pharmacologist in the University Hospital of Besançon, France, where she works on anti-infectious and cardiovascular agents. Moreover, she also works in the University of Burgundy-Franche–Comté (UFC), France. Her research focuses on interactions of antiplatelet agents on the platelet plasma membrane, integrating computer simulation approaches. She is working to improve understanding of membranotropic drugs to contribute to the optimization and development of novel antiplatelet candidates.

Christophe Ramseyer studied physics and chemistry at UFC. His PhD (awarded in 1994) was devoted to adsorption phenomena and surface sciences under the supervision of C. Girardet. After postdoctoral training with P. Zeppenfeld and G. Comsa at IGV-KFA Julich, Germany, he moved to UFC to obtain his research oversight qualification in nanosciences and growth of adsorbate on surfaces containing defects. Since 2002, he has been a professor at UFC, where he develops simulation studies applied to nanosciences, with a current focus on biophysics and drug targeting in cancer therapies.

© 2021 Elsevier Ltd. All rights reserved.

留言 (0)

沒有登入
gif